← Browse by Condition
Medical Condition
postoperative adjuvant treatment
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 3, Phase 4
ClinicalMetric tracks all active clinical trials for postoperative adjuvant treatment sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 3 1
Phase 4 1
Top Sponsors
1 trial
1 trial
1 trial
NCT05731258
Recruiting
Observational of Adjuvant Treatment of Breast Cancer With Liposomal Doxorubicin Regimen
Enrollment
150 pts
Location
China
Sponsor
Second Affiliated Hospital, Sc...
NCT07445048 Phase 3
Recruiting
Postoperative Radiotherapy Combined With Nimotuzumab Followed by Benmelstobart in High-Risk Patients With Head and Neck Squamous Cell Carcinoma
Enrollment
370 pts
Location
China
Sponsor
Shanghai Ninth People's Hospit...
NCT07073846 Phase 4
Recruiting
Effect of Lidocaine-Dexmedetomidine on Pain, Inflammation, and Oxidative Stress After Bariatric Surgery.
Enrollment
104 pts
Location
Mexico
Sponsor
Instituto Mexicano del Seguro ...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology